We are live on ! Find out more
TECH icon

Bio-Techne

280 hedge funds and large institutions have $4.39B invested in Bio-Techne in 2017 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 119 increasing their positions, 88 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

297% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $388K

63% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 19

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

35% more repeat investments, than reductions

Existing positions increased: 119 | Existing positions reduced: 88

18% more capital invested

Capital invested by funds: $3.72B → $4.39B (+$674M)

8.49% more ownership

Funds ownership: 392.07%400.56% (+8.5%)

3% more funds holding

Funds holding: 271280 (+9)

Holders
280
Holders Change
+9
Holders Change %
+3.32%
% of All Funds
6.96%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
31
Increased
119
Reduced
88
Closed
19
Calls
$1.54M
Puts
$388K
Net Calls
+$1.15M
Net Calls Change
+$978K

TECH Hedge Fund Activity: Q2 2017 in Review

280 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2017, worth a combined $4.39B — up 18% from $3.72B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new TECH positions and 19 closed out — a net gain of 12 holders — while 119 added to existing stakes and 88 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $100M. The largest seller was Select Equity Group, cutting an estimated $45.3M.

  • 280 institutional investors held Bio-Techne (TECH) as of Q2 2017, up from 271 in Q1 2017.
  • Funds reported $4.39B of Bio-Techne stock for Q2 2017, up 18% quarter-over-quarter.
  • 31 funds opened new Bio-Techne positions in Q2 2017 and 19 closed out, a net change of +12 holders.
  • The largest Bio-Techne buyer in Q2 2017 was Janus Henderson Group, an estimated $100M added.
  • The largest Bio-Techne seller in Q2 2017 was Select Equity Group, an estimated $45.3M sold.

Based on aggregated 13F filings for Q2 2017.